Zogenix Inc Quick Ratio (ZGNX) starting from the fourth quarter 2021 to fourth quarter 2020, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Zogenix Inc   (NASDAQ: ZGNX)

Zogenix Inc 's Quick Ratio

ZGNX's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the fourth quarter 2021, Quick Ratio fell to 3.09 below Zogenix Inc average.

Within Major Pharmaceutical Preparations industry 406 other companies have achieved higher Quick Ratio than Zogenix Inc in fourth quarter 2021. While Quick Ratio total ranking in the fourth quarter 2021 has deteriorated compared to the prior quarter from 797 to 1493.

Explain Quick Ratio?
How much Cash & cash equivalents ZGNX´s has?
What are ZGNX´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ZGNX Quick Ratio (Dec 31 2021)
Q4		 (Sep 30 2021)
Q3		 (Jun 30 2021)
Q2		 (Mar 31 2021)
Q1		 (Dec 31 2020)
Q4
Y / Y Current Liabilities Change 120.87 % -15.03 % -25.5 % -34.1 % -53.32 %
Y / Y Cash & cash equivalent Change -64.21 % -34.68 % 0.78 % 3.58 % 235.69 %
Quick Ratio MRQ 3.09 4.37 5.67 7.44 19.06
ZGNX's Total Ranking # 1493 # 797 # 728 # 687 #
Seq. Current Liabilities Change 24.57 % 13.1 % 18.47 % 32.33 % -52.08 %
Seq. Cash & cash equivalent Change -12.04 % -12.78 % -9.64 % -48.38 % 60.54 %



Quick Ratio fourth quarter 2021 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 407
Healthcare Sector # 709
Overall Market # 1493


Quick Ratio Statistics
High Average Low
13.99 4.3 0.48
(Dec 31 2017)   (Jun 30 2013)




Financial Statements
Zogenix Inc 's Current Liabilities $ 98 Millions Visit ZGNX's Balance sheet
Zogenix Inc 's Cash & cash equivalent $ 302 Millions Visit ZGNX's Balance sheet
Source of ZGNX's Sales Visit ZGNX's Sales by Geography


Cumulative Zogenix Inc 's Quick Ratio

ZGNX's Quick Ratio for the trailling 12 Months

ZGNX Quick Ratio

 (Dec 31 2021)
12 Months		 (Sep 30 2021)
12 Months		 (Jun 30 2021)
12 Months		 (Mar 31 2021)
12 Months		 (Dec 31 2020)
12 Months
Y / Y Current Liabilities TTM Growth -4.53 % -32.1 % -29.32 % -17.01 % 1.29 %
Y / Y Cash & cash equivalent TTM Growth -32.38 % 26.97 % 66.86 % 57.91 % 50.28 %
Quick Ratio TTM 4.85 8.04 8.31 7.61 6.84
Total Ranking TTM # 5327 # 5269 # 5277 # 338 #
Seq. Current Liabilities TTM Growth 21.34 % -5.25 % -8.24 % -9.51 % -13.69 %
Seq. Cash & cash equivalent TTM Growth -26.87 % -8.29 % 0.14 % 0.69 % 37.31 %

Quick ratio ranking by company, industry and sector >> Back to ZGNX Financial Strength Comparisons >> Go to Compare ZGNX Quick Ratio to its Competitors

On the trailing twelve months basis Due to growth in Current Liabilities in the Q4 2021 to $97.69 millions, cumulative Quick Ratio decreased to 4.85 above the ZGNX average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 589 other companies have achieved higher Quick Ratio than Zogenix Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the third quarter 2021 from 5269 to 5327.

Explain Quick Ratio?
How much Cash & cash equivalents ZGNX´s has?
What are ZGNX´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 590
Healthcare Sector # 1167
Within the Market # 5327


trailing twelve months Quick Ratio Statistics
High Average Low
9.78 4.78 0.79
(Sep 30 2018)   (March 31, 2014)




Companies with similar Quick Ratio in the quarter ending Dec 31 2021, within Major Pharmaceutical Preparations Industry Quick RatioDec 31 2021 MRQ Cash & cash equivalentDec 31 2021 MRQ Current Liabilities
Capricor Therapeutics inc   8.44 $ 34.885  Millions$ 4.133  Millions
Revance Therapeutics Inc   8.40 $ 446.492  Millions$ 53.181  Millions
Aclaris Therapeutics Inc   8.35 $ 191.414  Millions$ 22.931  Millions
Clene Inc   8.35 $ 50.288  Millions$ 6.026  Millions
Avenue Therapeutics Inc   8.34 $ 3.763  Millions$ 0.451  Millions
Enveric Biosciences Inc   8.33 $ 17.356  Millions$ 2.084  Millions
Immunome Inc   8.32 $ 49.229  Millions$ 5.917  Millions
Gracell Biotechnologies Inc   8.28 $ 287.578  Millions$ 34.715  Millions
Cytokinetics Incorporated  8.27 $ 471.638  Millions$ 56.997  Millions
Igm Biosciences Inc   8.26 $ 229.542  Millions$ 27.780  Millions
Tonix Pharmaceuticals Holding Corp   8.23 $ 178.679  Millions$ 21.716  Millions
Gossamer Bio Inc   8.16 $ 325.218  Millions$ 39.859  Millions
Sierra Oncology Inc   8.13 $ 104.749  Millions$ 12.884  Millions
Histogen Inc   8.02 $ 18.685  Millions$ 2.330  Millions
G1 Therapeutics Inc   8.01 $ 221.186  Millions$ 27.613  Millions
Vincerx Pharma Inc   8.01 $ 111.459  Millions$ 13.919  Millions
Trevena inc   7.97 $ 66.923  Millions$ 8.394  Millions
Lipocine Inc   7.94 $ 44.618  Millions$ 5.617  Millions
Larimar Therapeutics Inc   7.92 $ 70.097  Millions$ 8.846  Millions
Unicycive Therapeutics Inc  7.88 $ 16.579  Millions$ 2.105  Millions
Elicio Therapeutics Inc   7.86 $ 88.756  Millions$ 11.296  Millions
Liquidia Corporation  7.85 $ 57.494  Millions$ 7.327  Millions
Guardion Health Sciences Inc   7.84 $ 9.090  Millions$ 1.159  Millions
Phio Pharmaceuticals Corp  7.84 $ 24.057  Millions$ 3.068  Millions
Global Blood Therapeutics Inc.  7.78 $ 684.717  Millions$ 87.998  Millions
Intra cellular Therapies Inc   7.73 $ 412.333  Millions$ 53.357  Millions
Opiant Pharmaceuticals Inc   7.72 $ 52.869  Millions$ 6.846  Millions
Scynexis Inc   7.71 $ 104.484  Millions$ 13.546  Millions
Lite Strategy Inc   7.64 $ 173.200  Millions$ 22.673  Millions
Crescent Biopharma Inc   7.64 $ 90.307  Millions$ 11.824  Millions

Date modified: 2026-09-08T15:10:30+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.